TMS Philadelphia, OCD Therapy Philadelphia

Who Can Use TMS Therapy?

TMS therapy is often connected to depression treatments, but that is not all the medical procedure is used to treat. In 2008, TMS therapy became an FDA-approved treatment for depression. Transcranial magnetic stimulation is seen as safe and effective. There is no need for hospital stays, pain medications, or sedation. Treatments are administered in a comfortable office with a talented and friendly staff. The best TMS Philadelphia has to offer allows you to go directly back to work after sessions.

TMS therapy is safe for most people, but the treatments are only administered to patients that meet strict requirements. These include:

  • Diagnosis from a medical doctor
  • Traditional methods of treatment are not effective
  • Cannot have stimulator implants or non-removable conductive metals (near the head)
  • Do not suffer from a history of seizures
  • No traumatic brain injuries

The best TMS Philadelphia offers never administers TMS therapy without first talking with patients, going over their medical history, and customizing treatments.

Although TMS is mostly associated with treating depression, it is also used for a growing number of other psychological and mental issues. TMS therapy is used for:

  • Addiction (nicotine and drugs)
  • Alzheimer’s Disease
  • Stroke Rehabilitation
  • Anxiety Disorders (OCD)
  • Post-Traumatic Stress Disorder
  • Parkinson’s Disease
  • Autism

It is important to keep in mind that studies are still being conducted to test the effectiveness of TMS for the above-listed ailments. Reaching out for the best TMS Philadelphia can help you identify if transcranial magnetic stimulation is right for you.

Related Reading
Copyright © 2019 Spark TMS Therapeutic Center. All Rights Reserved.
Looking for TMS Philadelphia & Depression Help Philadelphia? Then you have come to the right place. Now Brainsway TMS is FDA cleared for OCD. The TMS protocol offered at Spark TMS is established for the patient under the direct supervision of Andrew Peshek, M.D.